WAM
DRTSW icon

Warberg Asset Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Warberg Asset Management’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-22,900
Closed -$6.64K – 248
2023
Q1 		$6.64K Hold
22,900
– – ﹤0.01% 210
2022
Q4 		$5.73K Sell
22,900
-1,300
-5% -$398 ﹤0.01% 223
2022
Q3 		$11K Buy
24,200
+4,200
+21% +$2.48K ﹤0.01% 230
2022
Q2 		$10K Buy
+20,000
New +$11.1K ﹤0.01% 208

Other funds holding DRTSW

Corbin Capital Partners
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Atalaya Capital Management
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Moore Capital Management
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
Chicago Partners Investment Group
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Tenor Capital Management
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
Whitebox Advisors
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Warberg Asset Management's DRTSW Position: Q2 2023 in Review

Warberg Asset Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2023, closing a stake of 22,900 shares — an estimated $6.64K sold.

Warberg Asset Management first reported a position in DRTSW in Q2 2022 and held it in 4 quarters. The position peaked at $11K in Q3 2022. 28 funds tracked by Wall St. Rank hold DRTSW as of Q2 2023.

  • Warberg Asset Management reported no remaining Alpha Tau Medical Warrant position as of Q2 2023 after selling out during the quarter.
  • Warberg Asset Management sold 22,900 Alpha Tau Medical Warrant shares in Q2 2023, an estimated $6.64K.
  • Warberg Asset Management first reported a position in Alpha Tau Medical Warrant in Q2 2022 and held it in 4 quarters.
  • Warberg Asset Management's Alpha Tau Medical Warrant position peaked at $11K in Q3 2022.
  • 28 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2023.

Based on Warberg Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.